GAMIDA CELL
Gamida Cell is dedicated to making a significant difference in the clinical practice of modern medicine by first creating, then tapping the regenerative power of therapeutic stem cells. Gamida Cell is a leader in the development of stem cell therapy technologies and products. The therapies are based on expanded populations of cord blood stem cells, for the treatment of illnesses with significant unmet clinical needs such as blood cancers, autoimmune and metabolic diseases as well as neutropenia.
GAMIDA CELL
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
1998-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.gamida-cell.com
Total Employee:
101+
Status:
Active
Contact:
97226595616
Email Addresses:
[email protected]
Total Funding:
267.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Alcresta
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
Eyevensys
Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.
Moximed
Moximed improves the standard of care for patients with osteoarthritis and investigates therapies to treat affected joints.
Novian Health
Novian Health is a medical device company transforming healthcare through innovation such as Novilase laser ablation for breast tumors.
P-Cure
P-Cure is a biotech company has developed a patient centric proton therapy solution with clinical benefits and financial advantages.
Reapplix
Reapplix identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds.
Shanghai Cell Therapy Group
Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.
Sino Biological
Sino Biological is a specialist provider of protein, antibody and gene products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Highbridge Capital Management
Highbridge Capital Management investment in Post-IPO Debt - Gamida Cell
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Gamida Cell
Israel Biotech Fund
Israel Biotech Fund investment in Series F - Gamida Cell
Novartis
Novartis investment in Series F - Gamida Cell
Clal Biotechnology Industries
Clal Biotechnology Industries investment in Series F - Gamida Cell
Shavit Capital
Shavit Capital investment in Series F - Gamida Cell
Israel Healthcare Ventures
Israel Healthcare Ventures investment in Series F - Gamida Cell
VMS Asset Management
VMS Asset Management investment in Series F - Gamida Cell
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Gamida Cell
Clal Biotechnology Industries
Clal Biotechnology Industries investment in Series E - Gamida Cell
Official Site Inspections
http://www.gamida-cell.com Semrush global rank: 4.14 M Semrush visits lastest month: 2.89 K
- Host name: 251.183.232.35.bc.googleusercontent.com
- IP address: 35.232.183.251
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Gamida Cell"
Gamida Cell - Crunchbase Company Profile & Funding
Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases.See details»
Who We Are - Gamida Cell
Gamida Cell has been in operation for over 20 years, developing deep expertise in the science of expanding and enhancing cells. We have assembled a strong team of pioneers with respected track records in cell therapy research and …See details»
BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement …
Nov 21, 2024 – BioLineRx to receive $10 million upfront payment from Ayrmid Ltd. (parent company of Gamida Cell) plus up to $87 million in commercial milestones, as well as royalties …See details»
Company Overview - Gamida Cell
Cell Press Reviews, Trends in Immunology, April 2019, Vol. 40, No. 4 *Gamida Cell’s lead development candidate consists of omidubicel (expanded hematopoietic stem cells) and …See details»
Gamida Cell Company Profile 2024: Valuation, Funding ... - PitchBook
Gamida Cell Ltd is a clinical-stage biopharmaceutical company that is pioneering a diverse immunotherapy pipeline of potentially curative cell therapy candidates for patients with solid …See details»
Gamida Cell Ltd. - AnnualReports.com
Gamida Cell is an advanced cell therapy company committed to cures for patients with blood cancers and serious blood diseases. They harness their cell expansion platform to create therapies with the potential to redefine standards of care in …See details»
Gamida Cell Announces Commencement of Restructuring Process …
The newly reorganized Gamida Cell will issue contingent value rights with a potential aggregate maximum value of $27.5 million to holders of Gamida Cell’s ordinary shares, subject to the ...See details»
Gamida Cell - Funding, Financials, Valuation & Investors
Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases.See details»
Gamida Cell Announces New Leadership Under Ownership of …
BOSTON, June 18, 2024--Gamida Cell (the "Company"), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced new executive leadership following a …See details»
Gamida Cell - Contacts, Employees, Board Members, Advisors
Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases.See details»
Gamida Cell has a second chance to be an Israeli success story
May 12, 2024 Specializing in cancer treatment, Gamida Cell’s claim to fame is advancing potentially curative cell therapies for various cancers—specifically through its proprietary …See details»
Gamida off-the-shelf cell therapy approved - BioProcess Insider
Apr 18, 2023 Omisirge was developed by Israeli biotech Gamida Cell. The firm worked with contract development and manufacturing organization (CDMO) Lonza for clinical supply from …See details»
Gamida Cell Completes International Restructuring - Cooley
Boston – June 21, 2024 – Cooley advised longtime biotech client Gamida Cell Ltd. and its wholly owned subsidiary, Gamida Cell Inc., in its global restructuring through a novel use of debt …See details»
Gamida restructuring deal to support Omisirge
Apr 2, 2024 Having failed to find a commercialization partner, Gamida Cell has entered into a Restructuring Support Agreement to ensure continued rollout of approved cell therapy …See details»
Cash-strapped Gamida steps up search for strategic alternatives
Jan 29, 2024 At the same time, Gamida made the “difficult” decision to deprioritize preclinical work on natural killer (NK) cell therapies, including GDA-301, GDA-501 and GDA-601.See details»
Gamida Cell Announces FDA Acceptance of Biologics License …
Aug 1, 2022 Gamida Cell is pioneering a diverse immunotherapy pipeline of potentially curative cell therapy candidates for patients with solid tumor and blood cancers and other serious blood …See details»
Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy ...
Nov 4, 2023 Data further characterize the mechanism for Gamida Cell’s proprietary nicotinamide (NAM) technology’s expansion and enhancement of cellsBOSTON, Nov. 04, 2023 (GLOBE …See details»
Omidubicel vs standard myeloablative umbilical cord blood ...
Oct 21, 2021 Omidubicel (Gamida Cell, Jerusalem, Israel) is a patient-specific cell product derived from a single banked UCB unit. It consists of an ex vivo expanded CD133 + fraction …See details»
Gamida Cell wins FDA approval for new cord blood-based therapy …
Apr 17, 2023 The FDA on Monday approved Israel-based Gamida Cell's Omisirge (omidubicel-onlv), an allogeneic cord blood-based cell therapy used to quicken the recovery of white blood …See details»